New research suggests some medications 'may not always be appropriate' for people with dementia ...

What families need to know about a renewed debate over rules for nursing homes that sedate dementia patients.

A massive UK study of more than 165,000 dementia patients is raising new concerns about a commonly prescribed medicine and ...

Yentli Soto Albrecht has a rare genetic form of ALS and is working on research at Penn that could one day prove life-saving.

There’s growing evidence that people can take steps to keep their brains healthy and reduce the risk of dementia.

Labour MSP Paul Sweeney has claimed there is a wider breakdown in patient safety at Stobhill Hospital in Glasgow, after an ...

Summary: Women make up nearly two-thirds of Alzheimer’s patients, and researcher may have just discovered a massive reason why. A new study found that when the protein alpha-synuclein (typically ...

Houston Methodist scientists have uncovered an unexpected side of a protein best known for its link to brain diseases. The ...

The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend ...

Cognito raised $105 million as it awaits trial data that it hopes will convince the FDA to authorize its Alzheimer’s treatment device.

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to reach patients ...